Upneeq for the treatment of speculum-induced blepharoptosis

Mustafa Safi, Jason Bacharach

Research output: Contribution to journalArticlepeer-review


There are many different etiologies of blepharoptosis. Speculum-induced blepharoptosis can occur after intraocular surgery. A series of patients whose speculum-induced blepharoptosis was successfully treated with the recently U.S. Food and Drug Administration–approved drug Upneeq (oxymetazoline hydrochloride 0.1% ophthalmic solution, RVL Pharmaceuticals, Inc.) is presented.

Original languageEnglish
Pages (from-to)E00048
JournalJCRS Online Case Reports
Issue number2
StatePublished - Feb 1 2021


Dive into the research topics of 'Upneeq for the treatment of speculum-induced blepharoptosis'. Together they form a unique fingerprint.

Cite this